Adjuvant Radiotherapy and Chemotherapy Offer a Recurrence and Survival Benefit in Patients with Resected Perihilar Cholangiocarcinoma

被引：0
|
作者：
Im, J. H. [1 ]
Choi, G. H. [2 ]
Lee, W. J. [2 ]
Han, D. H. [2 ]
Park, S. W. [3 ]
Bang, S. M. [4 ]
Choi, H. J. [1 ]
Seong, J. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Div Hepatopancreaticobiliary Surg, Dept Surg, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Div Gastroenterol, Dept Internal Med, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.1975
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2509
引用
收藏
页码：E221 / E222
页数：2
相关论文
共 50 条
  • [1] Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma
    Im, Jung Ho
    Choi, Gi Hong
    Lee, Woo Jung
    Han, Dai Hoon
    Park, Seung Woo
    Bang, Seungmin
    Choi, Hye Jin
    Seong, Jinsil
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (08) : 2435 - 2445
  • [2] Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma
    Jung Ho Im
    Gi Hong Choi
    Woo Jung Lee
    Dai Hoon Han
    Seung Woo Park
    Seungmin Bang
    Hye Jin Choi
    Jinsil Seong
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2435 - 2445
  • [3] Adjuvant Therapy Is Associated with Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study
    Nassour, Ibrahim
    Mokdad, Ali
    Porembka, Matthew R.
    Choti, Michael A.
    Mansour, John C.
    Minter, Rebecca M.
    Wang, Sam C.
    Yopp, Adam C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : S129 - S129
  • [4] Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study
    Nassour, Ibrahim
    Mokdad, Ali A.
    Porembka, Matthew R.
    Choti, Michael A.
    Polanco, Patricio M.
    Mansour, John C.
    Minter, Rebecca M.
    Wang, Sam C.
    Yopp, Adam C.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1193 - 1201
  • [5] Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study
    Ibrahim Nassour
    Ali A. Mokdad
    Matthew R. Porembka
    Michael A. Choti
    Patricio M. Polanco
    John C. Mansour
    Rebecca M. Minter
    Sam C. Wang
    Adam C. Yopp
    Annals of Surgical Oncology, 2018, 25 : 1193 - 1201
  • [6] Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
    Se Jun Park
    Kabsoo Shin
    In-Ho Kim
    Tae Ho Hong
    Younghoon Kim
    Myung-ah Lee
    World Journal of Gastrointestinal Oncology, 2023, (04) : 677 - 688
  • [7] Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
    Park, Se Jun
    Shin, Kabsoo
    Kim, In-Ho
    Hong, Tae Ho
    Kim, Younghoon
    Lee, Myung-ah
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (04) : 677 - 688
  • [8] Survival Benefit of Adjuvant Chemotherapy in Resected Squamous Carcinoma of the Gallbladder
    Olecki, Elizabeth
    Brahmbhatt, Rushin
    Peng, June
    Vining, Charles
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S192 - S192
  • [9] Adjuvant Chemotherapy for Resected Intrahepatic Cholangiocarcinoma Confers No Survival Advantage.
    Sharib, Jeremy
    Liu, Annie
    McIntyre, Sarah
    Rhodin, Kristen E.
    Kemeny, Nancy E.
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Soares, Kevin C.
    Wei, Alice C.
    Drebin, Jeffrey
    Kingham, T. Peter
    D'Angelica, Michael I.
    Uronis, Hope
    Strickler, John H.
    Morse, Michael A.
    Zani, Sabino
    Allen, Peter J.
    Jarnagin, William R.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S10 - S10
  • [10] Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
    Sharib, Jeremy
    Liu, Annie
    McIntyre, Sarah Margaret Helena
    Rhodin, Kristen Elizabeth
    Kemeny, Nancy E.
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Soares, Kevin
    Wei, Alice Chia-chi
    Drebin, Jeffrey A.
    Kingham, T. Peter
    D'Angelica, Michael Ian
    Uronis, Hope Elizabeth
    Strickler, John H.
    Morse, Michael
    Zani, Sabino
    Allen, Peter J.
    Jarnagin, William R.
    Lidsky, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 560 - 560
12345